362 related articles for article (PubMed ID: 32289430)
1. Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand.
Niwa T; Takanobu J; Suzuki K; Sato Y; Yamaguchi Y; Hayashi SI
J Steroid Biochem Mol Biol; 2020 Jul; 201():105671. PubMed ID: 32289430
[TBL] [Abstract][Full Text] [Related]
2. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
3. Estrogen response element-GFP (ERE-GFP) introduced MCF-7 cells demonstrated the coexistence of multiple estrogen-deprivation resistant mechanisms.
Fujiki N; Konno H; Kaneko Y; Gohno T; Hanamura T; Imami K; Ishihama Y; Nakanishi K; Niwa T; Seino Y; Yamaguchi Y; Hayashi S
J Steroid Biochem Mol Biol; 2014 Jan; 139():61-72. PubMed ID: 24128438
[TBL] [Abstract][Full Text] [Related]
4. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
6. Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M; Tsuboi K; Niwa T; Ishida T; Hayashi SI
Breast Cancer; 2019 May; 26(3):272-281. PubMed ID: 30328006
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer.
Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA
Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor activation by tobacco smoke condensate in hormonal therapy-resistant breast cancer cells.
Niwa T; Shinagawa Y; Asari Y; Suzuki K; Takanobu J; Gohno T; Yamaguchi Y; Hayashi SI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):448-457. PubMed ID: 27632897
[TBL] [Abstract][Full Text] [Related]
9. WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.
Sikora MJ; Jacobsen BM; Levine K; Chen J; Davidson NE; Lee AV; Alexander CM; Oesterreich S
Breast Cancer Res; 2016 Sep; 18(1):92. PubMed ID: 27650553
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor-positive breast cancer cells.
Kurebayashi J; Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T
Cancer Sci; 2017 May; 108(5):918-930. PubMed ID: 28211214
[TBL] [Abstract][Full Text] [Related]
11. Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.
Vydra N; Janus P; Kus P; Stokowy T; Mrowiec K; Toma-Jonik A; Krzywon A; Cortez AJ; Wojtas B; Gielniewski B; Jaksik R; Kimmel M; Widlak W
Elife; 2021 Nov; 10():. PubMed ID: 34783649
[TBL] [Abstract][Full Text] [Related]
12. Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity.
Likhite VS; Stossi F; Kim K; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 2006 Dec; 20(12):3120-32. PubMed ID: 16945990
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
Chang SB; Miron P; Miron A; Iglehart JD
J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
[TBL] [Abstract][Full Text] [Related]
14. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
[TBL] [Abstract][Full Text] [Related]
16. Membrane-initiated steroid signaling action of estrogen and breast cancer.
Song RX
Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
[TBL] [Abstract][Full Text] [Related]
17. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of potential implication of membrane estrogen binding sites on ERE-dependent transcriptional activity and intracellular estrogen receptor-alpha regulation in MCF-7 breast cancer cells.
Seo HS; Leclercq G
J Steroid Biochem Mol Biol; 2002 Jan; 80(1):109-23. PubMed ID: 11867270
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.
Kumar A; Klinge CM; Goldstein RE
Int J Oncol; 2010 May; 36(5):1067-80. PubMed ID: 20372779
[TBL] [Abstract][Full Text] [Related]
20. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.
Tian X; Zhang Z
IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
